Cardiac resynchronization therapy: From treatment to prevention

European Heart Journal

Volumn 32, Issue 13, 2011, Pages 1580-1582

  Leclercq, Christophe ^a   Singh, Jagmeet P ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DISEASE COURSE; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79959979873     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr016     Document Type: Review

References (13)

1. Bristow M, Saxon L, Boehmer J, Krueger K, Kass DA, De Marco T, Carson P, DiCarlo L, De MMets D, White B, DeVries D, Feldman A. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
2. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization therapy on morbidity and mortality in heart failure (the CArdiac REsynchronization-Heart Failure [CARE-HF] Trial). N Eng J Med 2005;352:1539-1549.
3. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M; European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboarion with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-2295. (Pubitemid 47428944)
4. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010;31:2677-2687.
5. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the reverse (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009;54:1837-1846.
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown M, Daubert J, Estes M III, Foster E, Greenberg H, Higgings S, Pfeffer M, Solomon S, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.
7. Tang A, Wells G, Talajic P, Arnold M, Sheldoon R, Connolly S, Hohnloser S, Nichol G, Birnie D, Sapp J, Yee R, Healey J, Rouleau JL. Cardiac- resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-2395.
8. Barsheshet A, Goldenberg I, Moss AJ, Eldar M, Huang DT, McNitt S, Klein HU, Hall WJ, Brown MW, Goldberger JJ, Goldstein RE, Schuger C, Zareba W, Daubert JP. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J 2011;32:1622-1630. First published on 12 November 2010. doi:10.1093/eurheartj/ ehq407.
9. Barsheshet A, Moss AJ, Eldar M, Huang DT, Hall WJ, Klein HU, McNitt S, Steinberg JS, Wilber DJ, Zareba W, Goldenberg I. Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction. Eur Heart J 2011;32:1614-1621. First published on 12 November 2010. doi:10.1093/eurheartj/ehq392.
10. Linde C, Abraham WT, Gold MR, Daubert C; REVERSE Study Group. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. J Am Coll Cardiol 2010;56:1826-1831.
11. Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC, on behalf of the REVERSE study group. Cost-effectiveness of cardiac resyncronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Eur Heart J 2011;32:1631-1639. First published on 25 November 2010. doi:10.1093/eurheartj/ehq408.
12. Yao G, Freemantle N, Calvert M, Bryan S, Daubert C, Cleland J. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007;28:42-51. (Pubitemid 46134956)
13. Feldman AM, de Lissovoy G, Bristow MR, Saxon L, De Marco T, Kass DA, Boehmer J, Singh S, Whellan D, Carson P, Boscoe A, Backer T, Gunderman M. Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2311-2321. (Pubitemid 41785503)